142 related articles for article (PubMed ID: 31666188)
1. Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantation.
Nomura S; Konishi A; Tsubokura Y; Azuma Y; Hotta M; Yoshimura H; Nakanishi T; Fujita S; Satake A; Katayama Y; Ohta S; Hayashi K; Ishii K; Ito T
Transpl Immunol; 2019 Dec; 57():101247. PubMed ID: 31666188
[TBL] [Abstract][Full Text] [Related]
2. Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.
Fujiwara H; Maeda Y; Sando Y; Nakamura M; Tani K; Ishikawa T; Nishimori H; Matsuoka K; Fujii N; Kondo E; Tanimoto M
Transfusion; 2016 Apr; 56(4):886-92. PubMed ID: 26711692
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Recombinant Thrombomodulin for the Prophylaxis of Veno-Occlusive Complication in Allogeneiccit Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Kashyap R; Anwer F; Iqbal MA; Khalid F; Khan A; Ali MA; Anwar MY; Chaudhary A; Jaan A
Hematol Oncol Stem Cell Ther; 2023 Jan; 16(2):93-101. PubMed ID: 34655527
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Recombinant Human Soluble Thrombomodulin in Treating Disseminated Intravascular Coagulation Complicating Allogeneic Hematopoietic Stem Cell Transplantation.
Inoue Y; Matsunawa M; Sano F; Miura I
Acta Haematol; 2018; 140(2):121-127. PubMed ID: 30227394
[TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant thrombomodulin therapy and soluble human leukocyte antigen-G levels during hematopoietic stem cell transplantation.
Nomura S; Ito T; Katayama Y; Ota S; Hayashi K; Fujita S; Satake A; Ishii K
Transpl Immunol; 2019 Apr; 53():28-33. PubMed ID: 30543860
[TBL] [Abstract][Full Text] [Related]
6. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
7. [Successful treatment with recombinant thrombomodulin in transplant-associated thrombotic microangiopathy following HLA-haploidentical transplantation].
Otsuka Y; Kondo T; Nomura R; Yamashita K; Takaori-Kondo A
Rinsho Ketsueki; 2019; 60(11):1560-1566. PubMed ID: 31839635
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
[TBL] [Abstract][Full Text] [Related]
9. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation.
Ikezoe T; Takeuchi A; Chi S; Takaoka M; Anabuki K; Kim T; Sakai M; Taniguchi A; Togitani K; Yokoyama A
Eur J Haematol; 2013 Nov; 91(5):442-7. PubMed ID: 23952647
[TBL] [Abstract][Full Text] [Related]
11. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.
de Fontbrune FS; Galambrun C; Sirvent A; Huynh A; Faguer S; Nguyen S; Bay JO; Neven B; Moussi J; Simon L; Xhaard A; Resche-Riggon M; O'Meara A; Fremeaux-Bacchi V; Veyradier A; Socié G; Coppo P; de Latour RP
Transplantation; 2015 Sep; 99(9):1953-9. PubMed ID: 25651309
[TBL] [Abstract][Full Text] [Related]
12. [Thrombotic complications after hematopoietic stem cell transplantation].
Nomura S
Rinsho Ketsueki; 2017; 58(5):516-522. PubMed ID: 28592769
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic recombinant thrombomodulin treatment prevents hepatic sinusoidal obstruction syndrome in high-risk pediatric patients that undergo hematopoietic stem cell transplants.
Yamamoto S; Toyama D; Sugishita Y; Kaneko R; Okamoto N; Koganesawa M; Fujita S; Akiyama K; Matsuno R; Isoyama K
Pediatr Transplant; 2018 Nov; 22(7):e13269. PubMed ID: 30003636
[TBL] [Abstract][Full Text] [Related]
14. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
[TBL] [Abstract][Full Text] [Related]
15. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
16. Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen.
Ikezoe T; Yang J; Nishioka C; Yokoyama A
Bone Marrow Transplant; 2015 Jan; 50(1):113-20. PubMed ID: 25243628
[TBL] [Abstract][Full Text] [Related]
17. [The risk factors and prognosis of transplant-associated thrombotic microangiopathy following acute graft-versus-host disease].
Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
Zhonghua Nei Ke Za Zhi; 2013 Feb; 52(2):156-60. PubMed ID: 23967613
[TBL] [Abstract][Full Text] [Related]
18. Intrapatient variability in concentration/dose ratio of tacrolimus predicts transplant-associated thrombotic microangiopathy.
Sagou K; Fukushima N; Ukai S; Goto M; Ozeki K; Kohno A
Int J Hematol; 2021 Jan; 113(1):63-72. PubMed ID: 32876853
[TBL] [Abstract][Full Text] [Related]
19. Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell Transplantation.
El-Bietar J; Warren M; Dandoy C; Myers KC; Lane A; Wallace G; Davies SM; Jodele S
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1994-2001. PubMed ID: 26150023
[TBL] [Abstract][Full Text] [Related]
20. [A comparison of clinical characteristics and prognosis of adult acute graft-versus-host disease between human leukocyte antigen- identical and -mismatched allogeneic hematopoietic stem cell transplantation].
Zhao X; Xu L; Liu D; Han T; Wang Y; Zhang X; Yan C; Chen H; Han W; Wang J; Zhao T; Li Y; Zhang B; Zhao X; Liu K; Huang X
Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):35-9. PubMed ID: 24674726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]